retatrutide fda status Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide FDA Approval Status 2026:
Description
References 1 AustinJ.KimbleJ

View insurance and pricing details

Supply chain disruptions at Novo Nordisk and Eli Lilly facilities further delayed production

however, the duration youll be on this medication depends on your unique biology and goals

By month 4 (week 16), over 85% of patients reported minimal to no side effects

It does so through stimulation of gluconeogenesis and glycogenolysis in the liver
